Clinical trial
Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma
NCT00154791 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00154791 |
|---|---|
| Title | Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma |
| Official title | Phase I/II Trial of Biweekly Gemcitabine, Oxaliplatin, and 48-Hour Infusion of High-Dose 5-FU/Leucovorin (GOFL) in Advanced Pancreatic Adenocarcinoma |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Health Research Institutes, Taiwan |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Adenocarcinoma |
| Intervention type | Drug |
| Interventions | oxaliplatin, gemcitabine, 5-FU/LV |
| Enrollment | 45 |
| Start date | Mar 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: